General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited.

Journal: Prostate international
Published Date: Oct 14, 2017

Abstract

BACKGROUND: In 2006, a county-wide survey of general practitioners (GPs) in the United Kingdom (UK) identified a reluctance to refer younger men with abnormal prostate specific antigen (PSA) levels. Younger men have the most to gain from early-detection of prostate cancer (PCa), which remains a national government priority in the UK and around the world. We sought to assess changes in perception of abnormal PSA-values amongst UK GPs over the past 10 years.

Authors

  • David R Thurtle
    Academic Urology Group, Department of Surgery, University of Cambridge, UK and West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, UK.
  • Emma M Gordon
    Department of Urology, West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, UK.
  • Robert D Brierly
    Department of Urology, Ipswich Hospital NHS Trust, Ipswich, UK.
  • Ciaran J Conway
    General Practice Registrar, Severn Deanery, University of Bristol, Bristol, UK.
  • John McLoughlin
    Department of Urology, West Suffolk Hospital NHS Foundation Trust, Bury St Edmunds, UK.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals